| Jeffrey Jay Fagerland, DO | |
|
330 Laurel St Ste 1100, Des Moines, IA 50314-3044 | |
| (515) 288-3287 | |
| Not Available |
| Full Name | Jeffrey Jay Fagerland |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 330 Laurel St Ste 1100, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811095045 | NPI | - | NPPES |
| 2102251 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 02469 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Obstetrical And Gynecological Associates Of Des Moines Plc | 7315041027 | 7 |
News Archive
Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 5 days ago
| Entity Name | West Des Moines Ob/gyn Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326014101 PECOS PAC ID: 3375537129 Enrollment ID: O20040413001651 |
News Archive
Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 5 days ago
| Entity Name | Central Iowa Ob/gyn Specialists Of Des Moines Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124129804 PECOS PAC ID: 1658368675 Enrollment ID: O20040429001244 |
News Archive
Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 5 days ago
| Entity Name | Obstetrical & Gynecological Associates Of Des Moines Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932139151 PECOS PAC ID: 7315041027 Enrollment ID: O20070404000497 |
News Archive
Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Jay Fagerland, DO 330 Laurel St Ste 1100, Des Moines, IA 50314-3044 Ph: (515) 288-3287 | Jeffrey Jay Fagerland, DO 330 Laurel St Ste 1100, Des Moines, IA 50314-3044 Ph: (515) 288-3287 |
News Archive
Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older
On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
A team of UK-based researchers at the University of Bristol and the University of Exeter found that university students report fewer daily contacts amid the coronavirus pandemic. However, most of these contacts were those not affiliated with the university, indicating potential transmission to other people other than students and staff.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 5 days ago
Dr. Lindsey Lea Jenkins, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 330 Laurel St Ste 1100, Des Moines, IA 50314 Phone: 515-288-3287 | |
Paula R Mahone, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1215 Pleasant St, Suite 116, Des Moines, IA 50309 Phone: 515-241-8383 Fax: 515-241-8386 | |
Kevin Kremer, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1221 Pleasant St Ste 400, Des Moines, IA 50309 Phone: 515-875-9290 Fax: 515-241-4162 | |
Paul Gisi, MD FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Ste 405, Des Moines, IA 50309 Phone: 515-243-8842 Fax: 515-282-9806 | |
Karen L Drake, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1440 Pleasant St, Suite 1, Des Moines, IA 50314 Phone: 515-241-8383 Fax: 515-241-8386 | |
Vaun W Dejong, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite 405, Des Moines, IA 50309 Phone: 515-243-8842 Fax: 515-282-9806 | |
Caroline Boehnke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 330 Laurel St Ste 1100, Des Moines, IA 50314 Phone: 515-288-3287 Fax: 515-288-3200 |